Vitamin D-Loaded Nanostructured Lipid Carrier (NLC): A New Strategy for Enhancing Efficacy of Doxorubicin in Breast Cancer Treatment

. (Source: Nutrition and Cancer)

from #Cancer-Sfakianakis via simeraentaxei on Inoreader http://ift.tt/2v8cT3c
via IFTTT Medicine by Alexandros G.Sfakianakis,Anapafseos 5 Agios Nikolaos,Crete 72100,Greece,tel :00302841026182 & 00306932607174

Vitamin D-Loaded Nanostructured Lipid Carrier (NLC): A New Strategy for Enhancing Efficacy of Doxorubicin in Breast Cancer Treatment

Sequential Therapy of Breast Cancer Cell Lines with Vitamin C and Quercetin Improves the Efficacy of Chemotherapeutic Drugs

. (Source: Nutrition and Cancer)

from #Cancer-Sfakianakis via simeraentaxei on Inoreader http://ift.tt/2v876uw
via IFTTT Medicine by Alexandros G.Sfakianakis,Anapafseos 5 Agios Nikolaos,Crete 72100,Greece,tel :00302841026182 & 00306932607174

Sequential Therapy of Breast Cancer Cell Lines with Vitamin C and Quercetin Improves the Efficacy of Chemotherapeutic Drugs

North America Head and Neck Cancer Diagnostics Market is projected to reach 3997.38 million by 2021, at a CAGR of … – Medgadget (blog)

Head-and-Neck2.jpg

Medgadget (blog) North America Head and Neck Cancer Diagnostics Market is projected to reach 3997.38 million by 2021, at a CAGR of …
Medgadget (blog)
According to the report “North America Head and Neck Cancer Diagnostics Market by Test Type (Diagnostic imaging, Biopsy, Endoscopy and Dental diagnostics), and by Region – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast (2016 …

and more »

from #Cancer-Sfakianakis via simeraentaxei on Inoreader http://ift.tt/2w06H9M
via IFTTT Medicine by Alexandros G.Sfakianakis,Anapafseos 5 Agios Nikolaos,Crete 72100,Greece,tel :00302841026182 & 00306932607174

North America Head and Neck Cancer Diagnostics Market is projected to reach 3997.38 million by 2021, at a CAGR of … – Medgadget (blog)

PD-L1 induced by IFN- γ from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancer

ConclusionsIFN- γ was not always successful as an antitumor agent. It also can promote tumor cells to evade immune surveillance. Researchers should be cautious in using IFN-γ as a therapeutic agent for cancer treatment. (Source: International Journal of Clinical Oncology)

from #Cancer-Sfakianakis via simeraentaxei on Inoreader http://ift.tt/2tDaYiG
via IFTTT Medicine by Alexandros G.Sfakianakis,Anapafseos 5 Agios Nikolaos,Crete 72100,Greece,tel :00302841026182 & 00306932607174

PD-L1 induced by IFN- γ from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancer

Retrospective comparison of S-1 plus cisplatin versus S-1 monotherapy for the treatment of advanced gastric cancer patients with positive peritoneal cytology but without gross peritoneal metastasis

ConclusionAdding cisplatin to long-term S-1 monotherapy did not significantly improve the outcome of CY+ advanced gastric cancer patients. (Source: International Journal of Clinical Oncology)

from #Cancer-Sfakianakis via simeraentaxei on Inoreader http://ift.tt/2uZgOyj
via IFTTT Medicine by Alexandros G.Sfakianakis,Anapafseos 5 Agios Nikolaos,Crete 72100,Greece,tel :00302841026182 & 00306932607174

Retrospective comparison of S-1 plus cisplatin versus S-1 monotherapy for the treatment of advanced gastric cancer patients with positive peritoneal cytology but without gross peritoneal metastasis